Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cardiovit is a cardiovascular nutraceutical developed and manufactured by Universal Corporation in Kenya under its Unicare brand. It is formulated to support heart health through a combination of metabolic cofactors, antioxidants, and essential minerals. The supplement typically contains Coenzyme Q10 (CoQ10), which is vital for the mitochondrial electron transport chain and ATP production in cardiac myocytes, and levocarnitine, which facilitates the transport of long-chain fatty acids into the mitochondria for energy production. Additionally, Cardiovit includes B-vitamins (pyridoxine, cyanocobalamin, and folic acid) to help regulate homocysteine levels, a known risk factor for vascular disease, and magnesium to support normal myocardial function. It is marketed as a supportive therapy for maintaining cardiovascular health and managing conditions such as heart failure and hypertension.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cardiovit.